Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2018 | AMPK in Alzheimer’s Disease: a double-edged sword?

Grahame Hardie, FRS, FRSE, FMedSci, of the University of Dundee, Dundee, UK, gave a talk at the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK, about the possible protective role of the AMP-activated kinase (AMPK) pathway on neurodegenerative diseases, such as Alzheimer’s disease. This is a complex issue, however, since contradictory research also exists, which implicates AMPK as a Tau protein kinase, suggesting it has a detrimental effect on the progression of such diseases. Prof. Hardie discusses context-dependent variables that may contribute to this confusing issue.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.